peptides #fda #longevity #glp1 #precisionmedicine #compounding Katherine Erickson BPC 157 OLYMPEX SOLUTIONS The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York 503A vs. 503B: A Quick Guide to Compounding Pharmacy Designations & Regulations The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York